CLINICAL TRIALS PROFILE FOR DIACOMIT
✉ Email this page to a colleague
All Clinical Trials for DIACOMIT
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03819647 ↗ | Evaluation of the Efficacy of Stiripentol (Diacomit) as Monotherapy for the Treatment of Primary Hyperoxaluria | Completed | Biocodex | Phase 2 | 2019-05-21 | Evaluation of the efficacy of stiripentol (Diacomit) as monotherapy for the treatment of primary hyperoxaluria. Pilot clinical study, open, prospective and multicenter. |
NCT05419180 ↗ | Study of Interest of Stiripentol and Carbamazepine in the Treatment of Patients With Pharmacoresistant Focal Epilepsies | Not yet recruiting | Biocodex | Phase 4 | 2022-06-01 | This is a monocentric, open-label clinical study, presenting a retrospective part and a prospective part, studying the data of patients with drug-resistant focal epilepsies and treated with the combination of stiripentol (Diacomit®) and Carbamazepine. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DIACOMIT
Condition Name
Clinical Trial Locations for DIACOMIT
Clinical Trial Progress for DIACOMIT
Clinical Trial Phase
Clinical Trial Sponsors for DIACOMIT
Sponsor Name